In order to meet the unfulfilled requirements of a varied patient population, we have created distinct AI-assisted drug discovery approaches that precisely detect cancer-causing mutations which have not been targeted, and then pair them with possible medication candidates in a tumor-agnostic manner. We are a trailblazing precision oncology firm leading the way in developing cancer treatments guided by our exclusive functional genomics. Firmly grounded in science and creativity, our goal is to empathetically contribute to resolving cancer.